3 ML liraglutide 6 MG/ML Pen Injector — RxCUI 897122
RxNorm drug concept · Semantic clinical drug
RxCUI 897122
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI897122
Official name3 ML liraglutide 6 MG/ML Pen Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asliraglutide 18 MG per 3 ML Pen Injector; liraglutide 6 MG/ML in 3 ML Pen Injector
FDA products mapped15
Package NDCs mapped26
Reported Medicaid activity (SDUD)234,356 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Liraglutide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Saxenda is a daily injectable medication that works by mimicking a hormone called GLP-1, which your body naturally makes after eating. It helps reduce your appetite, makes you feel...
- What exactly is Saxenda and how is it different from other weight-loss options?
- Yes, nausea is the most common side effect, and it's especially common in the first few weeks. That's actually why your prescriber starts you at a low dose and slowly increases it...
- The nausea is really bothering me — is that normal, and will it get better?
🕸️ Concept Web — How 3 ML liraglutide 6 MG/ML Pen Injector Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
3 ML liraglutide 6 MG/ML Pen Injector
RxCUI 897122 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Liraglutide
475968IN
-
Liraglutide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Victoza
897123BN
-
Victoza
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Liraglutide Pen Injector
1653594SCDF -
Liraglutide Injectable Product
1163230SCDG -
Liraglutide Pen Injector [Victoza]
1653597SBDF -
Victoza Injectable Product
1186578SBDG -
Pen Injector
1649571DF -
Injectable Product
1151126DFG
-
Liraglutide Pen Injector
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Liraglutide 6 MG/ML
897120SCDC -
3 ML liraglutide 6 MG/ML Pen Injector [Victoza]
897126SBD -
Liraglutide 6 MG/ML [Victoza]
897124SBDC
-
Liraglutide 6 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Liraglutide 6 MG/ML
SCDC · 897120 -
Liraglutide Pen Injector
SCDF · 1653594 -
Liraglutide Injectable Product
SCDG · 1163230
Brand-Name Concepts
-
3 ML liraglutide 6 MG/ML Pen Injector [Victoza]
SBD · 897126 -
Liraglutide 6 MG/ML [Victoza]
SBDC · 897124 -
Liraglutide Pen Injector [Victoza]
SBDF · 1653597 -
Victoza Injectable Product
SBDG · 1186578 -
Victoza
BN · 897123
📦 FDA Products & Package NDCs
15 products · 26 package NDCs
26 package NDCs map to RxCUI 897122 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9144-02 | 2 SYRINGE, PLASTIC in 1 CARTON (0143-9144-02) / 3 mL in 1 S... | Liraglutide | Hikma Pharmaceuticals USA Inc. | 2024-12-24 |
| 00143-9144-03 | 3 SYRINGE, PLASTIC in 1 CARTON (0143-9144-03) / 3 mL in 1 S... | Liraglutide | Hikma Pharmaceuticals USA Inc. | 2024-12-24 |
| 00169-4060-12 | 2 SYRINGE, PLASTIC in 1 CARTON (0169-4060-12) / 3 mL in 1 S... | Victoza | Novo Nordisk | 2010-01-25 |
| 00169-4060-13 | 3 SYRINGE, PLASTIC in 1 CARTON (0169-4060-13) / 3 mL in 1 S... | Victoza | Novo Nordisk | 2010-01-25 |
| 00169-4060-90 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4060-90) / 3 mL in 1 S... | Victoza | Novo Nordisk | 2010-01-25 |
| 00169-4060-99 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4060-99) / 3 mL in 1 S... | Victoza | Novo Nordisk | 2015-02-13 |
| 00480-3667-20 | 2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 S... | Liraglutide | Teva Pharmaceuticals USA, Inc. | 2024-06-24 |
| 00480-3667-22 | 3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 S... | Liraglutide | Teva Pharmaceuticals USA, Inc. | 2024-06-24 |
| 14403-3400-01 | 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1) | Liraglutide | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-06-21 |
| 14403-3400-02 | 2 SYRINGE, PLASTIC in 1 CARTON (14403-3400-2) / 3 mL in 1 S... | Liraglutide | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-12-24 |
| 14403-3400-03 | 3 SYRINGE, PLASTIC in 1 CARTON (14403-3400-3) / 3 mL in 1 S... | Liraglutide | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-12-24 |
| 50090-2853-00 | 3 SYRINGE, PLASTIC in 1 CARTON (50090-2853-0) / 3 mL in 1 S... | Victoza | A-S Medication Solutions | 2017-02-08 |
| 50090-4503-00 | 3 SYRINGE, PLASTIC in 1 CARTON (50090-4503-0) / 3 mL in 1 S... | Victoza | A-S Medication Solutions | 2019-09-04 |
| 50090-7501-00 | 3 SYRINGE, PLASTIC in 1 CARTON (50090-7501-0) / 3 mL in 1 S... | Liraglutide | A-S Medication Solutions | 2025-01-27 |
| 69097-0920-67 | 2 SYRINGE, PLASTIC in 1 CARTON (69097-920-67) / 3 mL in 1 S... | LIRAGLUTIDE | Cipla USA Inc. | 2026-01-22 |
| 69097-0920-68 | 3 SYRINGE, PLASTIC in 1 CARTON (69097-920-68) / 3 mL in 1 S... | LIRAGLUTIDE | Cipla USA Inc. | 2026-01-22 |
| 70377-0094-52 | 2 SYRINGE, PLASTIC in 1 CARTON (70377-094-52) / 3 mL in 1 S... | Liraglutide | Biocon Pharma Inc. | 2026-04-25 |
| 70377-0094-53 | 3 SYRINGE, PLASTIC in 1 CARTON (70377-094-53) / 3 mL in 1 S... | Liraglutide | Biocon Pharma Inc. | 2026-04-25 |
| 70748-0346-02 | 2 SYRINGE, PLASTIC in 1 CARTON (70748-346-02) / 3 mL in 1 S... | Liraglutide | Lupin Pharmaceuticals, Inc. | 2025-10-02 |
| 70748-0346-03 | 3 SYRINGE, PLASTIC in 1 CARTON (70748-346-03) / 3 mL in 1 S... | Liraglutide | Lupin Pharmaceuticals, Inc. | 2025-10-02 |
| 71288-0563-84 | 3 SYRINGE, PLASTIC in 1 CARTON (71288-563-84) / 3 mL in 1 S... | Liraglutide | Meitheal Pharmaceuticals Inc. | 2025-04-02 |
| 71288-0563-85 | 2 SYRINGE, PLASTIC in 1 CARTON (71288-563-85) / 3 mL in 1 S... | Liraglutide | Meitheal Pharmaceuticals Inc. | 2025-04-02 |
| 72603-0745-02 | 2 SYRINGE, PLASTIC in 1 CARTON (72603-745-02) / 3 mL in 1 S... | Liraglutide | NorthStar Rx LLC | 2026-03-01 |
| 72603-0745-03 | 3 SYRINGE, PLASTIC in 1 CARTON (72603-745-03) / 3 mL in 1 S... | Liraglutide | NorthStar Rx LLC | 2026-03-01 |
| 81607-0018-01 | 3 SYRINGE, PLASTIC in 1 CARTON (81607-018-01) / 3 mL in 1 S... | LIRAGLUTIDE | Orbicular Pharmaceutical Technologies Private Limited | 2026-01-21 |
| 81607-0018-02 | 2 SYRINGE, PLASTIC in 1 CARTON (81607-018-02) / 3 mL in 1 S... | LIRAGLUTIDE | Orbicular Pharmaceutical Technologies Private Limited | 2026-01-21 |
Observed labelers:
Novo Nordisk (4) ·
A-S Medication Solutions (3) ·
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) (3) ·
Biocon Pharma Inc. (2) ·
Cipla USA Inc. (2) ·
Hikma Pharmaceuticals USA Inc. (2)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.